3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Brain Neoplasms
6
Neoplasm Metastasis
2
Hematologic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Multiple Myeloma
1
Meningioma
1
Lymphoma
1
Lung Neoplasms
1
Leukemia
1
Hypogonadism
1
Head and Neck Neoplasms
1
Cognitive/Functional Effects
1
Cognitive Dysfunction
1
Breast Neoplasms, Male
1
Breast Neoplasms
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
pembrolizumab
47
Carboplatin
35
Paclitaxel
28
Specimen Handling
20
Cyclophosphamide
17
Capecitabine
16
Magnetic Resonance Spectroscopy
15
sacituzumab govitecan
13
Gemcitabine
13
Biopsy
13
Taxes
12
130-nm albumin-bound paclitaxel
11
Albumin-Bound Paclitaxel
9
olaparib
8
Doxorubicin
8
Nivolumab
7
fludarabine
6
Cisplatin
6
eribulin
5
atezolizumab
5
Radiotherapy
5
Docetaxel
5
durvalumab
4
Immunoglobulin G
4
Fulvestrant
4
Epirubicin
4
Drug Therapy
4
Bevacizumab
4
veliparib
3
toripalimab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
Mental Status and Dementia Tests
×
90 days
×
Clear all
No trials found.